Biotechnology
The Biotechnology industry has a total of 596 stocks, with a combined market cap of $1.29 trillion and total revenue of $123.29 billion.
Market Cap
1.29T
Revenue
123.29B
Profits
-33.68B
PE Ratio
n/a
Profit Margin
-27.32%
Dividend Yield
0.04%
596 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 136.35B | -0.15% | 1,224,595 | 12.95B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 95.57B | -0.32% | 700,840 | 16.90B |
| 3 | MRNA | Moderna, Inc. | 87.10B | -3.63% | 7,023,752 | 2.53B |
| 4 | ARGX | argenx SE | 59.84B | -0.95% | 303,579 | 5.92B |
| 5 | ONC | BeOne Medicines AG | 46.98B | -1.26% | 159,162 | 6.45B |
| 6 | RPRX | Royalty Pharma plc | 39.31B | -1.13% | 3,044,130 | 2.62B |
| 7 | RVMD | Revolution Medicines, Inc. | 36.09B | -3.15% | 2,553,347 | 197.56M |
| 8 | GMAB | Genmab A/S | 32.90B | 0.39% | 2,407,812 | 4.30B |
| 9 | ROIV | Roivant Sciences Ltd. | 27.98B | -2.33% | 8,730,715 | 41.08M |
| 10 | INSM | Insmed Incorporated | 26.96B | 1.42% | 2,233,033 | 1.52B |
| 11 | INCY | Incyte Corporation | 24.51B | -0.58% | 1,510,375 | 6.01B |
| 12 | ALNY | Alnylam Pharmaceuticals, Inc. | 21.39B | -3.22% | 2,164,849 | 5.01B |
| 13 | BNTX | BioNTech SE | 21.14B | -0.40% | 1,036,184 | 2.75B |
| 14 | ASND | Ascendis Pharma A/S | 17.82B | -1.33% | 870,212 | 1.37B |
| 15 | EXEL | Exelixis, Inc. | 16.37B | -2.75% | 2,683,673 | 2.50B |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 15.39B | -0.74% | 490,227 | 4.72B |
| 17 | BBIO | BridgeBio Pharma, Inc. | 15.07B | -1.20% | 1,347,295 | 945.54M |
| 18 | MTRI | Mentari Therapeutics, Inc. | 11.95B | 6.83% | 11,658 | - |
| 19 | TECH | Bio-Techne Corporation | 11.43B | -0.01% | 3,502,601 | 1.23B |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 11.23B | 1.33% | 2,020,680 | 3.66B |
| 21 | HALO | Halozyme Therapeutics, Inc. | 11.00B | -3.76% | 2,088,288 | 1.80B |
| 22 | KYMR | Kymera Therapeutics, Inc. | 10.74B | -1.35% | 912,473 | 102.24M |
| 23 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.85B | -0.80% | 493,606 | 1.43B |
| 24 | PCVX | Vaxcyte, Inc. | 9.75B | -2.78% | 707,760 | - |
| 25 | SMMT | Summit Therapeutics Inc. | 9.45B | -16.47% | 24,445,720 | - |
| 26 | SYRE | Spyre Therapeutics, Inc. | 9.44B | -4.45% | 824,688 | - |
| 27 | KRYS | Krystal Biotech, Inc. | 8.83B | -2.40% | 203,283 | 470.03M |
| 28 | TGTX | TG Therapeutics, Inc. | 8.79B | -2.71% | 1,731,471 | 897.76M |
| 29 | PRAX | Praxis Precision Medicines, Inc. | 8.67B | -5.44% | 668,041 | 7.46M |
| 30 | PTGX | Protagonist Therapeutics, Inc. | 8.15B | -4.67% | 565,185 | 551.69M |
| 31 | CORT | Corcept Therapeutics Incorporated | 7.58B | -5.10% | 1,097,640 | 963.65M |
| 32 | CGON | CG Oncology, Inc. | 7.57B | 13.95% | 9,881,594 | 6.17M |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.45B | -6.56% | 964,694 | 280.75M |
| 34 | CYTK | Cytokinetics, Incorporated | 7.41B | -5.27% | 1,756,305 | 113.29M |
| 35 | AXSM | Axsome Therapeutics, Inc. | 7.21B | -3.30% | 989,279 | 865.27M |
| 36 | ABVX | ABIVAX Société Anonyme | 7.04B | -4.53% | 840,132 | 5.33M |
| 37 | IMVT | Immunovant, Inc. | 6.89B | -2.63% | 1,053,958 | - |
| 38 | ORKA | Oruka Therapeutics, Inc. | 6.73B | -5.80% | 989,987 | - |
| 39 | TWST | Twist Bioscience Corporation | 6.59B | -5.88% | 2,574,419 | 459.43M |
| 40 | KOD | Kodiak Sciences Inc. | 6.57B | -9.41% | 980,376 | - |
| 41 | BLTE | Belite Bio, Inc | 6.55B | -1.10% | 191,270 | - |
| 42 | IBRX | ImmunityBio, Inc. | 6.36B | -0.66% | 12,804,953 | 182.57M |
| 43 | ARWR | Arrowhead Pharmaceuticals, Inc. | 6.25B | -7.47% | 1,863,749 | 450.82M |
| 44 | LGND | Ligand Pharmaceuticals Incorporated | 6.04B | -2.29% | 191,247 | 253.83M |
| 45 | CAI | Caris Life Sciences, Inc. | 6.02B | -8.85% | 3,701,689 | 1.05B |
| 46 | MIRM | Mirum Pharmaceuticals, Inc. | 5.98B | -2.56% | 506,487 | 670.78M |
| 47 | SRRK | Scholar Rock Holding Corporation | 5.43B | 3.08% | 2,663,182 | 570.00K |
| 48 | MANE | Veradermics, Incorporated | 5.40B | -1.24% | 487,688 | - |
| 49 | ERAS | Erasca, Inc. | 5.30B | -3.51% | 5,827,117 | - |
| 50 | PTCT | PTC Therapeutics, Inc. | 5.09B | -3.97% | 745,572 | 1.16B |
| 51 | DNTH | Dianthus Therapeutics, Inc. | 5.04B | -2.46% | 587,973 | 2.72M |
| 52 | EWTX | Edgewise Therapeutics, Inc. | 4.78B | -4.90% | 1,279,798 | - |
| 53 | COGT | Cogent Biosciences, Inc. | 4.78B | -3.92% | 1,451,668 | - |
| 54 | TVTX | Travere Therapeutics, Inc. | 4.77B | -1.88% | 1,189,537 | 651.03M |
| 55 | IONS | Ionis Pharmaceuticals, Inc. | 4.66B | -3.61% | 5,077,292 | 960.09M |
| 56 | DFTX | Definium Therapeutics, Inc. | 4.13B | -5.99% | 1,131,559 | - |
| 57 | TNGX | Tango Therapeutics, Inc. | 4.10B | -5.22% | 1,581,265 | 53.81M |
| 58 | CRSP | CRISPR Therapeutics AG | 3.92B | -4.43% | 2,394,688 | 25.17M |
| 59 | TARS | Tarsus Pharmaceuticals, Inc. | 3.88B | -1.99% | 874,962 | 682.20M |
| 60 | XENE | Xenon Pharmaceuticals Inc. | 3.86B | -3.01% | 1,104,811 | 7.50M |
| 61 | RLAY | Relay Therapeutics, Inc. | 3.82B | -4.53% | 1,651,500 | 10.35M |
| 62 | ABCL | AbCellera Biologics Inc. | 3.63B | -3.22% | 2,468,898 | 67.85M |
| 63 | PBLS | Parabilis Medicines, Inc. | 3.56B | 0.07% | 538,172 | 2.26M |
| 64 | ELVN | Enliven Therapeutics, Inc. | 3.50B | -2.42% | 694,273 | - |
| 65 | IOVA | Iovance Biotherapeutics, Inc. | 3.49B | -2.71% | 8,428,134 | 378.98M |
| 66 | IRON | Disc Medicine, Inc. | 3.49B | -4.26% | 816,009 | - |
| 67 | ARQT | Arcutis Biotherapeutics, Inc. | 3.43B | -3.93% | 1,701,586 | 508.68M |
| 68 | VKTX | Viking Therapeutics, Inc. | 3.42B | -8.28% | 3,468,773 | - |
| 69 | VRDN | Viridian Therapeutics, Inc. | 3.38B | -3.47% | 2,094,723 | 26.31M |
| 70 | ACAD | Acadia Pharmaceuticals Inc. | 3.23B | -0.43% | 2,116,858 | 1.20B |
| 71 | DYN | Dyne Therapeutics, Inc. | 3.13B | -2.68% | 1,849,633 | - |
| 72 | LEGN | Legend Biotech Corporation | 3.10B | -8.63% | 2,827,408 | 1.36B |
| 73 | TLX | Telix Pharmaceuticals Limited | 3.07B | -3.36% | 225,785 | 890.79M |
| 74 | ADMA | ADMA Biologics, Inc. | 2.99B | -1.54% | 3,050,998 | 519.15M |
| 75 | CELC | Celcuity Inc. | 2.98B | -5.90% | 730,854 | - |
| 76 | IDYA | IDEAYA Biosciences, Inc. | 2.94B | -4.62% | 588,580 | 36.54M |
| 77 | VCEL | Vericel Corporation | 2.93B | 0.91% | 975,027 | 324.17M |
| 78 | DNLI | Denali Therapeutics Inc. | 2.90B | -3.52% | 1,146,872 | 21.38M |
| 79 | XNCR | Xencor, Inc. | 2.66B | -4.56% | 1,033,600 | 200.49M |
| 80 | ZLAB | Zai Lab Limited | 2.64B | -4.59% | 735,361 | 441.73M |
| 81 | MBX | MBX Biosciences, Inc. | 2.64B | -5.04% | 391,272 | - |
| 82 | RCUS | Arcus Biosciences, Inc. | 2.43B | -3.27% | 1,082,635 | 100.00M |
| 83 | NAMS | NewAmsterdam Pharma Company N.V. | 2.33B | -3.38% | 1,682,623 | 25.94M |
| 84 | PHVS | Pharvaris N.V. | 2.28B | -2.76% | 307,768 | - |
| 85 | CLDX | Celldex Therapeutics, Inc. | 2.25B | -0.83% | 572,630 | 158.00K |
| 86 | LKFT | Lakefront Biotherapeutics NV | 2.20B | 2.38% | 292,620 | 1.13B |
| 87 | PVLA | Palvella Therapeutics, Inc. | 2.11B | -5.17% | 312,469 | - |
| 88 | BEAM | Beam Therapeutics Inc. | 2.09B | -8.28% | 3,332,610 | 146.64M |
| 89 | BHVN | Biohaven Ltd. | 2.08B | -0.14% | 1,765,298 | - |
| 90 | IMNM | Immunome, Inc. | 2.08B | -6.18% | 1,519,236 | 4.02M |
| 91 | AUPH | Aurinia Pharmaceuticals Inc. | 2.07B | -1.59% | 923,528 | 321.74M |
| 92 | REPL | Replimune Group, Inc. | 2.03B | -2.19% | 2,033,229 | - |
| 93 | SEPN | Septerna, Inc. | 1.98B | -2.18% | 385,337 | 96.27M |
| 94 | TRAX | First Tracks Biotherapeutics, Inc. | 1.96B | -1.15% | 440,033 | - |
| 95 | VERA | Vera Therapeutics, Inc. | 1.95B | -4.02% | 1,003,937 | 10.28M |
| 96 | HRMY | Harmony Biosciences Holdings, Inc. | 1.94B | -2.37% | 710,506 | 989.36M |
| 97 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.92B | -1.86% | 1,512,797 | 213.00M |
| 98 | FTRE | Fortrea Holdings Inc. | 1.91B | -2.03% | 1,117,771 | 2.67B |
| 99 | TRVI | Trevi Therapeutics, Inc. | 1.89B | -2.64% | 1,665,347 | - |
| 100 | ZBIO | Zenas BioPharma, Inc. | 1.89B | -0.29% | 630,393 | 11.00M |
| 101 | MAZE | Maze Therapeutics, Inc. | 1.85B | -1.25% | 710,013 | 20.00M |
| 102 | ZYME | Zymeworks Inc. | 1.83B | 0.80% | 969,740 | 265.97M |
| 103 | COAG | Hemab Therapeutics Holdings, Inc. | 1.83B | -4.42% | 413,699 | - |
| 104 | RXRX | Recursion Pharmaceuticals, Inc. | 1.81B | -8.79% | 19,788,026 | 68.23M |
| 105 | AGIO | Agios Pharmaceuticals, Inc. | 1.80B | -4.56% | 540,853 | 140.84M |
| 106 | WWB | Windward Bio Group AG | 1.74B | 5.40% | 237,397 | - |
| 107 | STOK | Stoke Therapeutics, Inc. | 1.74B | -0.19% | 581,586 | 28.21M |
| 108 | MESO | Mesoblast Limited | 1.65B | -6.18% | 119,089 | 120.25M |
| 109 | LYCA | Lycia Therapeutics, Inc. | 1.65B | -8.30% | 250,870 | 4.44M |
| 110 | VIR | Vir Biotechnology, Inc. | 1.64B | -3.82% | 6,781,891 | 302.80M |
| 111 | KLRA | Kailera Therapeutics, Inc. | 1.63B | -5.28% | 962,782 | - |
| 112 | SRPT | Sarepta Therapeutics, Inc. | 1.62B | -5.85% | 2,006,374 | 1.96B |
| 113 | RARE | Ultragenyx Pharmaceutical Inc. | 1.62B | -1.12% | 5,252,621 | 730.00M |
| 114 | NRIX | Nurix Therapeutics, Inc. | 1.61B | -4.84% | 2,156,608 | 701.94M |
| 115 | BRVE | Braveheart Bio, Inc. | 1.59B | -0.66% | 725,376 | - |
| 116 | PGEN | Precigen, Inc. | 1.54B | -5.29% | 3,838,206 | 156.94M |
| 117 | QURE | uniQure N.V. | 1.53B | -8.11% | 1,010,467 | 20.17M |
| 118 | SLS | SELLAS Life Sciences Group, Inc. | 1.52B | -4.96% | 7,970,766 | - |
| 119 | ADRX | ADARx Pharmaceuticals, Inc. | 1.50B | -1.41% | 667,015 | 6.13M |
| 120 | IMCR | Immunocore Holdings plc | 1.49B | -3.54% | 181,450 | 429.30M |
| 121 | KRSA | Korsana Biosciences, Inc. | 1.49B | 3.25% | 319,741 | - |
| 122 | NBTX | Nanobiotix S.A. | 1.47B | -6.91% | 103,757 | 13.15M |
| 123 | RAPP | Rapport Therapeutics, Inc. | 1.47B | -5.09% | 462,817 | 20.00M |
| 124 | DMRA | Damora Therapeutics, Inc. | 1.39B | 4.14% | 1,232,735 | - |
| 125 | LBRX | LB Pharmaceuticals Inc | 1.39B | -0.05% | 597,259 | - |
| 126 | NTLA | Intellia Therapeutics, Inc. | 1.38B | 1.65% | 6,611,185 | 52.89M |
| 127 | URGN | UroGen Pharma Ltd. | 1.38B | 7.33% | 3,982,620 | 250.25M |
| 128 | TYRA | Tyra Biosciences, Inc. | 1.36B | -1.45% | 803,184 | - |
| 129 | ANAB | AnaptysBio, Inc. | 1.36B | -1.12% | 483,750 | 60.04M |
| 130 | NUVB | Nuvation Bio Inc. | 1.36B | -3.76% | 8,010,216 | 201.73M |
| 131 | GENB | Generate Biomedicines, Inc. | 1.35B | -13.09% | 1,318,181 | 21.07M |
| 132 | NVAX | Novavax, Inc. | 1.33B | -5.45% | 4,730,218 | 411.65M |
| 133 | GPCR | Structure Therapeutics Inc. | 1.33B | -7.15% | 762,979 | - |
| 134 | AVLN | Avalyn Pharma Inc. | 1.32B | -1.72% | 329,069 | - |
| 135 | TSHA | Taysha Gene Therapies, Inc. | 1.32B | -0.98% | 3,384,009 | 5.49M |
| 136 | OCUL | Ocular Therapeutix, Inc. | 1.32B | -3.22% | 3,428,207 | 50.38M |
| 137 | INVA | Innoviva, Inc. | 1.31B | -2.84% | 814,095 | 438.32M |
| 138 | ABSI | Absci Corporation | 1.29B | -11.54% | 7,872,202 | 1.49M |
| 139 | GHRS | GH Research PLC | 1.29B | -1.83% | 644,007 | - |
| 140 | MLYS | Mineralys Therapeutics, Inc. | 1.29B | -5.22% | 1,116,102 | - |
| 141 | MNKD | MannKind Corporation | 1.27B | -4.24% | 2,794,563 | 413.37M |
| 142 | NKTR | Nektar Therapeutics | 1.25B | -2.23% | 842,470 | 52.19M |
| 143 | SLN | Silence Therapeutics plc | 1.23B | -0.15% | 625,458 | 456.00K |
| 144 | AAPG | Ascentage Pharma Group International | 1.22B | -9.10% | 12,764 | 94.61M |
| 145 | OMER | Omeros Corporation | 1.21B | -4.63% | 1,554,146 | 74.36M |
| 146 | KARD | Kardigan, Inc. | 1.20B | -7.02% | 395,703 | - |
| 147 | SVRA | Savara Inc. | 1.20B | -3.77% | 2,797,753 | - |
| 148 | VOR | Vor Biopharma Inc. | 1.17B | -2.32% | 763,708 | - |
| 149 | INBX | Inhibrx Biosciences, Inc. | 1.15B | -6.77% | 286,042 | 2.00M |
| 150 | DRTS | Alpha Tau Medical Ltd. | 1.11B | -10.54% | 2,288,211 | - |
| 151 | ANRO | Alto Neuroscience, Inc. | 1.09B | -8.19% | 789,244 | - |
| 152 | SGP | SpyGlass Pharma, Inc. | 1.08B | -1.95% | 246,130 | - |
| 153 | JBIO | Jade Biosciences, Inc. | 1.06B | -4.99% | 1,130,996 | - |
| 154 | SPTX | Seaport Therapeutics, Inc. | 1.02B | -4.30% | 387,017 | - |
| 155 | MLTX | MoonLake Immunotherapeutics | 998.30M | -6.16% | 1,396,045 | - |
| 156 | VSTM | Verastem, Inc. | 970.31M | -5.87% | 2,246,619 | 100.30M |
| 157 | ODTX | Odyssey Therapeutics, Inc. | 928.14M | 1.15% | 340,246 | 99.00K |
| 158 | AKTS | Aktis Oncology, Inc. | 901.69M | -2.77% | 597,517 | 12.39M |
| 159 | CRVS | Corvus Pharmaceuticals, Inc. | 894.14M | -0.38% | 751,024 | - |
| 160 | PHAR | Pharming Group N.V. | 891.25M | -0.08% | 10,483 | 386.75M |
| 161 | MGTX | MeiraGTx Holdings plc | 854.16M | -4.79% | 706,023 | 401.91M |
| 162 | CTY | City Therapeutics, Inc. | 844.87M | -6.19% | 238,264 | 14.34M |
| 163 | IMTX | Immatics N.V. | 843.38M | -3.44% | 762,157 | 49.33M |
| 164 | LTGO | Latigo Biotherapeutics, Inc. | 835.37M | -3.89% | 505,045 | - |
| 165 | RIGL | Rigel Pharmaceuticals, Inc. | 823.43M | -1.64% | 148,594 | 288.21M |
| 166 | SNDX | Syndax Pharmaceuticals, Inc. | 821.96M | -3.39% | 2,465,909 | 289.68M |
| 167 | IVA | Inventiva S.A. | 819.24M | -9.78% | 2,471,042 | 2.81M |
| 168 | BBTX | Bambusa Therapeutics, Inc. | 814.06M | -0.68% | 139,846 | - |
| 169 | GLUE | Monte Rosa Therapeutics, Inc. | 782.72M | -2.24% | 881,028 | 70.33M |
| 170 | ORIC | ORIC Pharmaceuticals, Inc. | 779.47M | -4.33% | 1,196,157 | - |
| 171 | LXRX | Lexicon Pharmaceuticals, Inc. | 779.16M | -2.23% | 1,482,062 | 38.54M |
| 172 | ARDX | Ardelyx, Inc. | 771.71M | -0.65% | 3,795,808 | 468.22M |
| 173 | OBX | Obsidian Therapeutics, Inc. | 763.51M | -1.59% | 727,802 | - |
| 174 | AURA | Aura Biosciences, Inc. | 751.42M | 1.55% | 779,114 | - |
| 175 | PRME | Prime Medicine, Inc. | 747.70M | -1.87% | 6,738,841 | 7.06M |
| 176 | SLDB | Solid Biosciences Inc. | 723.24M | -5.26% | 872,565 | - |
| 177 | SGMT | Sagimet Biosciences Inc. | 722.96M | -0.88% | 1,024,198 | - |
| 178 | OABI | OmniAb, Inc. | 713.26M | -0.41% | 1,234,643 | 40.21M |
| 179 | ANNX | Annexon, Inc. | 681.03M | -8.93% | 3,114,492 | - |
| 180 | APMD | Apnimed, Inc. | 677.75M | -3.78% | 257,008 | 108.80M |
| 181 | ATTO | Attovia Therapeutics, Inc. | 672.21M | -2.68% | 171,493 | 1.44M |
| 182 | JANX | Janux Therapeutics, Inc. | 668.12M | -3.96% | 788,664 | 23.29M |
| 183 | ALMS | Alumis Inc. | 667.28M | -8.21% | 2,200,379 | 7.24M |
| 184 | QUIT | Achieve Life Sciences, Inc. | 666.81M | -4.11% | 822,495 | - |
| 185 | NVCT | Nuvectis Pharma, Inc. | 657.17M | -5.58% | 265,409 | - |
| 186 | KURA | Kura Oncology, Inc. | 651.42M | -8.75% | 2,630,498 | 79.31M |
| 187 | DBVT | DBV Technologies S.A. | 647.43M | -6.81% | 142,684 | 3.74M |
| 188 | BCAX | Bicara Therapeutics Inc. | 647.28M | -2.69% | 1,102,821 | - |
| 189 | ANL | Adlai Nortye Group Ltd. | 645.91M | -5.47% | 172,020 | 18.06M |
| 190 | OLMA | Olema Oncology, Inc. | 644.78M | -2.65% | 2,139,722 | - |
| 191 | FDMT | 4D Molecular Therapeutics, Inc. | 636.52M | -7.69% | 968,930 | 96.06M |
| 192 | DSGN | Design Therapeutics, Inc. | 635.24M | -5.25% | 301,609 | - |
| 193 | IMMX | Immix Biopharma, Inc. | 626.92M | -4.59% | 1,004,634 | - |
| 194 | ABUS | Arbutus Biopharma Corporation | 619.30M | -1.22% | 3,403,715 | 181.49M |
| 195 | CGEM | Cullinan Therapeutics, Inc. | 616.75M | -7.59% | 866,715 | - |
| 196 | SRZN | Surrozen, Inc. | 616.07M | 2.25% | 274,400 | 10.53M |
| 197 | GERN | Geron Corporation | 606.81M | -2.60% | 9,308,969 | 217.52M |
| 198 | AVBP | ArriVent BioPharma, Inc. | 597.92M | -11.15% | 644,237 | 5.00M |
| 199 | CLYM | Climb Bio, Inc. | 583.86M | -4.05% | 676,061 | - |
| 200 | CBIO | Crescent Biopharma, Inc. | 577.81M | -4.59% | 417,072 | 15.00M |
| 201 | ACRS | Aclaris Therapeutics, Inc. | 571.80M | -8.04% | 9,950,115 | 6.40M |
| 202 | WVE | Wave Life Sciences, Inc. | 566.05M | -8.31% | 2,322,880 | 70.92M |
| 203 | SANA | Sana Biotechnology, Inc. | 563.31M | -6.93% | 4,351,517 | - |
| 204 | IAM | Iambic Therapeutics, Inc. | 561.70M | -9.54% | 457,253 | 18.25M |
| 205 | OBIO | Orchestra BioMed Holdings, Inc. | 560.38M | -1.79% | 755,585 | 31.21M |
| 206 | HELP | Helus Pharma Inc. | 560.37M | -13.53% | 12,843,527 | - |
| 207 | DNA | Ginkgo Bioworks Holdings, Inc. | 550.95M | -11.55% | 3,407,512 | 130.75M |
| 208 | ZVRA | Zevra Therapeutics, Inc. | 550.42M | 1.87% | 1,761,713 | 147.76M |
| 209 | VALN | Valneva SE | 544.90M | -0.18% | 10,673 | 163.30M |
| 210 | INDP | Indaptus Therapeutics, Inc. | 529.86M | 8.83% | 364,187 | - |
| 211 | ENTX | Entera Bio Ltd. | 525.90M | -2.89% | 208,543 | 42.00K |
| 212 | ETRA | Electra Therapeutics, Inc. | 521.59M | -6.00% | 394,876 | - |
| 213 | MNPR | Monopar Therapeutics Inc. | 487.72M | -0.04% | 200,030 | - |
| 214 | EPRX | Eupraxia Pharmaceuticals Inc. | 486.40M | -9.94% | 705,389 | - |
| 215 | RGNX | REGENXBIO Inc. | 484.02M | -4.19% | 908,119 | 153.91M |
| 216 | CAPR | Capricor Therapeutics, Inc. | 482.58M | -12.91% | 3,919,851 | 11.13M |
| 217 | NGNE | Neurogene Inc. | 482.33M | -2.63% | 244,301 | 925.00K |
| 218 | GYRE | Gyre Therapeutics, Inc. | 480.49M | 1.86% | 577,140 | 110.06M |
| 219 | STTK | Shattuck Labs, Inc. | 474.59M | 0.22% | 1,337,963 | 1.00M |
| 220 | OCS | Oculis Holding AG | 471.02M | -0.13% | 211,164 | 1.12M |
| 221 | PHAT | Phathom Pharmaceuticals, Inc. | 467.05M | -2.97% | 1,118,057 | 274.88M |
| 222 | MDXG | MiMedx Group, Inc. | 464.04M | -0.93% | 1,487,580 | 303.73M |
| 223 | CADL | Candel Therapeutics, Inc. | 455.77M | -6.29% | 3,269,762 | - |
| 224 | OVID | Ovid Therapeutics Inc. | 452.96M | -5.51% | 2,796,913 | 1.45M |
| 225 | FENC | Fennec Pharmaceuticals Inc. | 450.49M | 9.81% | 793,190 | 66.37M |
| 226 | DMAC | DiaMedica Therapeutics Inc. | 449.47M | -5.23% | 246,370 | - |
| 227 | ARVN | Arvinas, Inc. | 443.33M | -0.73% | 1,318,402 | 275.30M |
| 228 | ASMB | Assembly Biosciences, Inc. | 435.96M | 0.80% | 514,286 | 67.01M |
| 229 | BLSM | BlossomHill Therapeutics, Inc. | 433.86M | -2.64% | 98,608 | - |
| 230 | CTMX | CytomX Therapeutics, Inc. | 432.74M | -2.70% | 2,603,498 | 14.03M |
| 231 | AVTX | Avalo Therapeutics, Inc. | 426.16M | -5.03% | 1,116,528 | 59.00K |
| 232 | SLBT | SL Science Holding Limited | 410.31M | -1.03% | 35,887 | 3.27M |
| 233 | TECX | Tectonic Therapeutic, Inc. | 410.15M | -0.76% | 237,429 | - |
| 234 | PRTA | Prothena Corporation plc | 409.26M | -2.33% | 318,706 | 52.74M |
| 235 | IRD | Opus Genetics, Inc. | 390.48M | 1.51% | 975,299 | 7.91M |
| 236 | RLMD | Relmada Therapeutics, Inc. | 385.17M | -14.25% | 2,418,880 | - |
| 237 | MPLT | MapLight Therapeutics, Inc. | 383.47M | -4.83% | 305,244 | - |
| 238 | CRMD | CorMedix Inc. | 383.37M | 3.43% | 3,196,767 | 412.49M |
| 239 | ALEC | Alector, Inc. | 382.61M | 1.18% | 2,769,731 | 173.47M |
| 240 | CTNM | Contineum Therapeutics, Inc. | 379.70M | -1.93% | 348,145 | - |
| 241 | PBYI | Puma Biotechnology, Inc. | 379.47M | -5.53% | 548,858 | 231.83M |
| 242 | RZLT | Rezolute, Inc. | 375.55M | -2.05% | 4,180,382 | - |
| 243 | SPRY | ARS Pharmaceuticals, Inc. | 360.90M | -7.71% | 3,284,813 | 122.14M |
| 244 | LYEL | Lyell Immunopharma, Inc. | 360.18M | 2.45% | 345,037 | 15.00K |
| 245 | ASPE | Aspen Neuroscience, Inc. | 355.63M | -2.86% | 216,303 | - |
| 246 | PRLD | Prelude Therapeutics Incorporated | 352.12M | -1.16% | 306,850 | 21.57M |
| 247 | CCCC | C4 Therapeutics, Inc. | 347.99M | -3.99% | 3,106,063 | 32.28M |
| 248 | YDES | YD Bio Limited | 342.12M | -1.02% | 121,170 | 1.24M |
| 249 | AVIR | Atea Pharmaceuticals, Inc. | 330.85M | -4.19% | 310,522 | - |
| 250 | LRMR | Larimar Therapeutics, Inc. | 315.40M | -0.66% | 2,738,193 | - |
| 251 | PROK | ProKidney Corp. | 314.48M | -0.48% | 1,708,501 | 775.00K |
| 252 | ENTA | Enanta Pharmaceuticals, Inc. | 310.77M | -2.91% | 181,928 | 65.26M |
| 253 | BNTC | Benitec Biopharma Inc. | 308.46M | -5.53% | 133,358 | - |
| 254 | GALT | Galectin Therapeutics Inc. | 304.57M | -0.98% | 231,993 | - |
| 255 | AUTL | Autolus Therapeutics plc | 303.63M | -2.56% | 2,351,640 | 137.43M |
| 256 | ALT | Altimmune, Inc. | 303.56M | -5.17% | 6,088,082 | 26.00K |
| 257 | KYTX | Kyverna Therapeutics, Inc. | 300.94M | -5.74% | 767,375 | - |
| 258 | IPSC | Century Therapeutics, Inc. | 297.82M | -0.61% | 910,025 | 109.16M |
| 259 | VCRE | Vicore Pharma Holding AB (publ) | 296.31M | -1.93% | 12,229 | 383.48K |
| 260 | AGMB | AgomAb Therapeutics NV | 294.01M | -6.13% | 165,616 | - |
| 261 | EVMN | Evommune, Inc. | 293.58M | -6.95% | 671,363 | 10.00M |
| 262 | EIKN | Eikon Therapeutics, Inc. | 291.79M | -9.95% | 496,220 | - |
| 263 | IKT | Inhibikase Therapeutics, Inc. | 291.22M | -4.61% | 475,591 | 1.00 |
| 264 | SCTX | Scribe Therapeutics Inc. | 291.07M | -6.05% | 436,691 | 14.83M |
| 265 | PEPG | PepGen Inc. | 290.20M | -3.90% | 2,614,003 | - |
| 266 | TRXB | TRex Bio, Inc. | 289.95M | -21.21% | 123,215 | - |
| 267 | XFOR | X4 Pharmaceuticals, Inc. | 288.98M | -9.29% | 672,441 | 16.96M |
| 268 | EDIT | Editas Medicine, Inc. | 288.62M | -13.82% | 2,113,184 | 49.83M |
| 269 | AGEN | Agenus Inc. | 284.60M | -6.54% | 568,259 | 133.95M |
| 270 | FULC | Fulcrum Therapeutics, Inc. | 283.38M | -1.59% | 1,642,150 | 80.00M |
| 271 | ALLO | Allogene Therapeutics, Inc. | 279.60M | -3.78% | 8,706,774 | 4.64M |
| 272 | DTIL | Precision BioSciences, Inc. | 277.88M | -3.77% | 204,411 | 45.04M |
| 273 | SABS | SAB Biotherapeutics, Inc. | 270.27M | 1.35% | 388,163 | 114.70K |
| 274 | NAUT | Nautilus Biotechnology, Inc. | 267.48M | -9.48% | 4,157,764 | 424.00K |
| 275 | LXEO | Lexeo Therapeutics, Inc. | 267.39M | 12.54% | 37,573,111 | - |
| 276 | OCGN | Ocugen, Inc. | 262.28M | -6.62% | 9,049,022 | 4.78M |
| 277 | TTRX | Turn Therapeutics Inc. | 261.40M | -8.56% | 148,568 | - |
| 278 | PLX | Protalix BioTherapeutics, Inc. | 255.49M | -0.66% | 1,290,381 | 84.69M |
| 279 | CUVL | Clinuvel Pharmaceuticals Limited | 254.82M | -1.39% | 7,781 | 65.05M |
| 280 | INO | Inovio Pharmaceuticals, Inc. | 251.50M | -2.10% | 6,630,244 | 298.90K |
| 281 | QTTB | Q32 Bio Inc. | 248.07M | -4.82% | 344,084 | 53.74M |
| 282 | CAMP | Camp4 Therapeutics Corporation | 242.23M | 1.58% | 108,683 | 5.32M |
| 283 | RCKT | Rocket Pharmaceuticals, Inc. | 241.19M | -6.09% | 1,919,496 | - |
| 284 | FTH | Faeth Therapeutics, Inc. | 239.83M | -7.48% | 796,749 | - |
| 285 | ARCT | Arcturus Therapeutics Holdings Inc. | 239.52M | -0.60% | 740,700 | 30.51M |
| 286 | CABA | Cabaletta Bio, Inc. | 239.45M | -13.28% | 5,253,595 | - |
| 287 | VNDA | Vanda Pharmaceuticals Inc. | 230.39M | -4.51% | 839,225 | 229.28M |
| 288 | IMRX | Immuneering Corporation | 227.97M | -5.12% | 1,019,933 | - |
| 289 | BCYC | Bicycle Therapeutics plc | 222.90M | -5.64% | 676,101 | 83.53M |
| 290 | DRUG | Bright Minds Biosciences Inc. | 221.77M | -2.16% | 220,516 | - |
| 291 | VTVT | vTv Therapeutics Inc. | 220.12M | -10.16% | 20,830 | 36.84M |
| 292 | VOGX | Vogenx, Inc. | 213.62M | -13.74% | 195,232 | - |
| 293 | ACIU | AC Immune SA | 207.80M | -1.88% | 99,324 | 23.75M |
| 294 | LCTX | Lineage Cell Therapeutics, Inc. | 202.87M | -13.07% | 12,784,223 | 10.84M |
| 295 | GLSI | Greenwich LifeSciences, Inc. | 201.97M | -7.90% | 153,651 | - |
| 296 | KROS | Keros Therapeutics, Inc. | 196.83M | -2.62% | 193,875 | 40.76M |
| 297 | ARTV | Artiva Biotherapeutics, Inc. | 195.75M | -1.25% | 1,311,979 | 251.00K |
| 298 | NGEN | NervGen Pharma Corp. | 195.69M | -3.19% | 1,622,250 | - |
| 299 | MDWD | MediWound Ltd. | 193.63M | 5.04% | 175,793 | 10.01M |
| 300 | CGEN | Compugen Ltd. | 193.24M | -2.86% | 250,429 | 75.93M |
| 301 | RNAC | Cartesian Therapeutics, Inc. | 185.46M | -4.25% | 97,893 | 1.03M |
| 302 | PALI | Palisade Bio, Inc. | 184.66M | -8.04% | 1,665,288 | 500.00K |
| 303 | TRDA | Entrada Therapeutics, Inc. | 182.53M | -1.77% | 607,027 | 3.98M |
| 304 | SLGL | Sol-Gel Technologies Ltd. | 179.94M | -0.29% | 84,340 | 1.44M |
| 305 | WHWK | Whitehawk Therapeutics, Inc. | 177.62M | -1.63% | 261,759 | 7.15M |
| 306 | KRRO | Korro Bio, Inc. | 174.45M | -6.61% | 98,152 | 1.29M |
| 307 | IFRX | InflaRx N.V. | 173.89M | 0.85% | 1,037,298 | -38.53K |
| 308 | ACOG | Alpha Cognition Inc. | 170.52M | -5.66% | 166,407 | 20.20M |
| 309 | ANTX | AN2 Therapeutics, Inc. | 169.61M | -1.76% | 246,856 | - |
| 310 | ORMP | Oramed Pharmaceuticals Inc. | 169.60M | 5.12% | 346,559 | 2.00M |
| 311 | PYXS | Pyxis Oncology, Inc. | 168.65M | -10.76% | 847,898 | 11.04M |
| 312 | ELDN | Eledon Pharmaceuticals, Inc. | 166.54M | -6.86% | 1,164,816 | - |
| 313 | PRQR | ProQR Therapeutics N.V. | 166.52M | -16.31% | 685,396 | 23.46M |
| 314 | IVVD | Invivyd, Inc. | 158.96M | -7.63% | 3,317,110 | 60.69M |
| 315 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 158.75M | -7.48% | 801,955 | - |
| 316 | ZNTL | Zentalis Pharmaceuticals, Inc. | 157.23M | -5.88% | 1,449,257 | 26.87M |
| 317 | STRO | Sutro Biopharma, Inc. | 155.89M | -5.09% | 260,090 | 45.11M |
| 318 | HUMA | Humacyte, Inc. | 150.09M | -3.24% | 3,046,854 | 2.40M |
| 319 | ABEO | Abeona Therapeutics Inc. | 148.58M | 7.44% | 2,535,511 | 39.01M |
| 320 | VRXA | Veraxa Biotech AG | 147.77M | -5.86% | 55,168 | 29.54K |
| 321 | TARA | Protara Therapeutics, Inc. | 146.54M | -5.93% | 631,321 | - |
| 322 | SION | Sionna Therapeutics, Inc. | 141.13M | -6.31% | 554,366 | - |
| 323 | RNA | Atrium Therapeutics, Inc. | 138.70M | -14.38% | 337,582 | 38.82M |
| 324 | MGNX | MacroGenics, Inc. | 138.68M | -1.36% | 886,956 | 140.81M |
| 325 | FATE | Fate Therapeutics, Inc. | 138.59M | -10.94% | 2,253,854 | 4.75M |
| 326 | ALXO | ALX Oncology Holdings Inc. | 138.28M | -3.85% | 752,762 | - |
| 327 | MSLE | Satellos Bioscience Inc. | 138.12M | -2.41% | 25,045 | - |
| 328 | CNTN | Canton Strategic Holdings, Inc. | 133.02M | -4.09% | 722,811 | 4.55M |
| 329 | MENS | Jyong Biotech Ltd. | 131.39M | 0.57% | 29,013 | - |
| 330 | IPHA | Innate Pharma S.A. | 129.79M | 1.81% | 46,372 | 11.21M |
| 331 | YARW | Yarrow Bioscience, Inc. | 129.61M | -22.74% | 264,840 | - |
| 332 | ENGN | enGene Therapeutics Inc. | 126.66M | -21.58% | 1,994,845 | - |
| 333 | NTHI | NeOnc Technologies Holdings, Inc. | 126.08M | -7.54% | 282,403 | 39.99K |
| 334 | PYPD | PolyPid Ltd. | 124.92M | -1.76% | 211,749 | - |
| 335 | SPRB | Spruce Biosciences, Inc. | 121.43M | -2.45% | 102,926 | 697.00K |
| 336 | LENZ | LENZ Therapeutics, Inc. | 120.03M | -7.51% | 1,028,062 | 12.36M |
| 337 | CMPX | Compass Therapeutics, Inc. | 119.13M | -14.51% | 2,042,844 | 850.00K |
| 338 | UPB | Upstream Bio, Inc. | 117.84M | -22.66% | 1,993,948 | 2.87M |
| 339 | CDXS | Codexis, Inc. | 116.17M | -8.62% | 1,030,501 | 88.34M |
| 340 | OKUR | OnKure Therapeutics, Inc. | 111.38M | 4.56% | 682,256 | - |
| 341 | ARMP | Armata Pharmaceuticals, Inc. | 111.21M | -22.74% | 159,509 | 7.56M |
| 342 | NERV | Minerva Neurosciences, Inc. | 109.64M | -4.35% | 142,079 | - |
| 343 | ADAG | Adagene Inc. | 107.43M | -6.43% | 945,089 | 9.29M |
| 344 | FHTX | Foghorn Therapeutics Inc. | 107.33M | -13.53% | 829,189 | 112.13M |
| 345 | ZURA | Zura Bio Limited | 104.03M | -12.90% | 3,734,527 | - |
| 346 | ICCC | ImmuCell Corporation | 103.72M | 6.23% | 101,670 | 33.21M |
| 347 | UNCY | Unicycive Therapeutics, Inc. | 103.06M | 4.23% | 1,239,729 | - |
| 348 | CUE | Cue Biopharma, Inc. | 102.43M | -12.53% | 211,331 | 37.66M |
| 349 | MOLN | Molecular Partners AG | 102.30M | -8.21% | 4,079 | 856.30K |
| 350 | VYGR | Voyager Therapeutics, Inc. | 101.43M | -5.78% | 567,067 | 25.11M |
| 351 | IMUX | Immunic, Inc. | 98.65M | -3.86% | 171,029 | - |
| 352 | TVGN | Tevogen Inc. | 97.88M | 3.67% | 3,144 | - |
| 353 | OTLK | Outlook Therapeutics, Inc. | 96.41M | -4.12% | 4,210,577 | -1.16M |
| 354 | RTSN | Retension Pharmaceuticals, Inc. | 95.48M | -6.60% | 320,854 | - |
| 355 | NRXP | NRx Pharmaceuticals, Inc. | 93.02M | -1.83% | 728,159 | 3.39M |
| 356 | VANI | Vivani Medical, Inc. | 92.01M | 0.99% | 461,131 | - |
| 357 | NBP | NovaBridge Biosciences | 91.81M | -6.87% | 672,966 | - |
| 358 | CBUS | Cibus, Inc. | 91.71M | 6.19% | 102,110 | 4.53M |
| 359 | EQ | Equillium, Inc. | 90.12M | -10.85% | 570,708 | 4.39M |
| 360 | PMVP | PMV Pharmaceuticals, Inc. | 89.86M | -6.30% | 585,564 | - |
| 361 | ANIX | Anixa Biosciences, Inc. | 88.65M | -2.67% | 123,885 | - |
| 362 | BDTX | Black Diamond Therapeutics, Inc. | 87.93M | 4.08% | 713,890 | 70.00M |
| 363 | NKTX | Nkarta, Inc. | 86.76M | 1.68% | 969,264 | - |
| 364 | GNLX | Genelux Corporation | 86.04M | 2.95% | 278,109 | 8.00K |
| 365 | HURA | TuHURA Biosciences, Inc. | 84.76M | -4.32% | 1,326,561 | - |
| 366 | PLYX | Polaryx Therapeutics, Inc. | 83.24M | -5.65% | 14,855 | - |
| 367 | RLYB | Rallybio Corporation | 83.05M | -1.88% | 44,476 | 434.00K |
| 368 | SEER | Seer, Inc. | 81.95M | -5.73% | 238,842 | 14.08M |
| 369 | CLLS | Cellectis S.A. | 80.02M | -11.86% | 54,731 | 32.10M |
| 370 | TENX | Tenax Therapeutics, Inc. | 79.34M | -8.64% | 1,104,182 | - |
| 371 | CHRS | Coherus Oncology, Inc. | 78.18M | -3.73% | 3,648,825 | 53.64M |
| 372 | KZIA | Kazia Therapeutics Limited | 76.74M | -15.41% | 1,409,050 | 1.27M |
| 373 | TNYA | Tenaya Therapeutics, Inc. | 76.04M | -4.47% | 1,687,388 | 3.03M |
| 374 | AVXL | Anavex Life Sciences Corp. | 75.79M | -12.42% | 2,724,712 | - |
| 375 | RANI | Rani Therapeutics Holdings, Inc. | 75.32M | 2.66% | 810,531 | 6.58M |
| 376 | TLSA | Tiziana Life Sciences Ltd | 73.77M | 1.11% | 665,300 | - |
| 377 | NTRB | Nutriband Inc. | 70.62M | -4.75% | 25,415 | 1.62M |
| 378 | COYA | Coya Therapeutics, Inc. | 70.37M | -4.15% | 99,179 | 4.69M |
| 379 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 69.55M | -0.44% | 953,479 | - |
| 380 | NMRA | Neumora Therapeutics, Inc. | 69.43M | -13.85% | 1,499,083 | - |
| 381 | CNXU | Conexeu Sciences Inc. | 68.14M | 1.38% | 140,042 | - |
| 382 | NRXS | NeurAxis, Inc. | 68.13M | -11.44% | 521,424 | 6.53M |
| 383 | GOSS | Gossamer Bio, Inc. | 67.16M | 0.09% | 207,136 | 78.42M |
| 384 | PDSB | PDS Biotechnology Corporation | 66.97M | 5.90% | 5,288,449 | - |
| 385 | MNOV | MediciNova, Inc. | 65.96M | -3.94% | 95,562 | 935.72K |
| 386 | CRDF | Cardiff Oncology, Inc. | 65.95M | 16.75% | 25,841,331 | 559.00K |
| 387 | CSBR | Champions Oncology, Inc. | 65.14M | -0.53% | 645 | 60.66M |
| 388 | ATRA | Atara Biotherapeutics, Inc. | 64.24M | -16.88% | 45,220 | 3.97M |
| 389 | ACRV | Acrivon Therapeutics, Inc. | 62.57M | 0.69% | 342,969 | - |
| 390 | MAIA | MAIA Biotechnology, Inc. | 62.37M | 1.00% | 656,387 | - |
| 391 | OKYO | OKYO Pharma Limited | 61.66M | -12.96% | 3,710,017 | - |
| 392 | CGTX | Cognition Therapeutics, Inc. | 60.75M | -6.03% | 503,676 | - |
| 393 | FBIO | Fortress Biotech, Inc. | 57.03M | -9.04% | 376,698 | 69.99M |
| 394 | XBIT | XBiotech Inc. | 56.40M | -5.61% | 111,572 | - |
| 395 | NORD | Nordicus Partners Corporation | 55.98M | 14.34% | 27,637 | - |
| 396 | TNXP | Tonix Pharmaceuticals Holding Corp. | 55.96M | -4.32% | 1,214,382 | 43.05M |
| 397 | SPRO | Spero Therapeutics, Inc. | 55.11M | -5.35% | 594,654 | 41.56M |
| 398 | VRCA | Verrica Pharmaceuticals Inc. | 54.97M | -10.11% | 49,323 | 22.89M |
| 399 | BOLD | Boundless Bio, Inc. | 54.82M | -3.60% | 136,980 | - |
| 400 | CING | Cingulate Inc. | 54.53M | -12.79% | 479,641 | - |
| 401 | AZR | Azora Therapeutics, Inc. | 54.43M | -6.85% | 8,033 | - |
| 402 | HRTX | Heron Therapeutics, Inc. | 54.09M | -8.44% | 5,907,253 | 148.22M |
| 403 | CLNN | Clene Inc. | 52.70M | -6.63% | 123,844 | 238.00K |
| 404 | ELOX | Eloxx Pharmaceuticals, Inc. | 51.46M | -3.04% | 32,672 | - |
| 405 | MIST | Milestone Pharmaceuticals Inc. | 51.43M | -29.81% | 8,803,345 | 5.31M |
| 406 | XLO | Xilio Therapeutics, Inc. | 50.67M | -4.70% | 8,373 | 55.01M |
| 407 | MREO | Mereo BioPharma Group plc | 48.71M | -0.81% | 634,345 | 800.00K |
| 408 | HOWL | Werewolf Therapeutics, Inc. | 48.15M | 1.07% | 724,982 | 21.00M |
| 409 | INKT | MiNK Therapeutics, Inc. | 47.71M | 0.11% | 17,382 | 200.00K |
| 410 | ATNM | Actinium Pharmaceuticals, Inc. | 46.85M | -9.15% | 347,947 | 35.09M |
| 411 | ANVS | Annovis Bio, Inc. | 46.52M | -19.02% | 2,193,536 | - |
| 412 | RNXT | RenovoRx, Inc. | 46.07M | -8.18% | 824,463 | 2.78M |
| 413 | IBIO | iBio, Inc. | 45.45M | -3.42% | 595,071 | 1.08M |
| 414 | HYFT | MindWalk Holdings Corp. | 44.18M | -5.27% | 108,146 | 11.57M |
| 415 | ONCY | Oncolytics Biotech Inc. | 43.34M | -8.14% | 1,326,378 | - |
| 416 | PLRX | Pliant Therapeutics, Inc. | 42.92M | -0.55% | 999,034 | - |
| 417 | IBO | Impact BioMedical Inc. | 41.95M | -4.47% | 12,992 | 38.00K |
| 418 | ELTX | Elicio Therapeutics, Inc. | 41.89M | -1.33% | 209,497 | - |
| 419 | GANX | Gain Therapeutics, Inc. | 41.03M | -9.60% | 591,260 | - |
| 420 | DWTX | Dogwood Therapeutics, Inc. | 40.52M | -4.50% | 69,536 | 100.00K |
| 421 | CNTB | Connect Biopharma Holdings Limited | 40.49M | -5.05% | 560,437 | 3.67M |
| 422 | ALDX | Aldeyra Therapeutics, Inc. | 40.41M | 4.01% | 998,928 | - |
| 423 | APLM | Apollomics, Inc. | 39.51M | 0.90% | 21,630 | 445.00K |
| 424 | TIL | Instil Bio, Inc. | 39.00M | -5.43% | 138,888 | - |
| 425 | HYPD | Hyperion DeFi, Inc. | 38.38M | -4.26% | 312,926 | 1.91M |
| 426 | ALPS | Alps Group Inc | 38.27M | -2.54% | 38,885 | 3.74M |
| 427 | CRBU | Caribou Biosciences, Inc. | 38.12M | -2.51% | 2,149,200 | 9.44M |
| 428 | IRLA | IRulya Therapeutics Inc. | 38.00M | -6.13% | 215,407 | - |
| 429 | BMEA | Biomea Fusion, Inc. | 37.70M | -10.67% | 512,345 | - |
| 430 | EXOZ | eXoZymes, Inc. | 37.03M | 4.18% | 11,721 | -700.00 |
| 431 | GRCE | Grace Therapeutics, Inc. | 36.81M | -3.31% | 49,395 | - |
| 432 | IMA | ImageneBio, Inc. | 36.32M | -7.78% | 23,166 | 800.00K |
| 433 | SER | Serina Therapeutics, Inc. | 36.07M | 2.16% | 56,776 | 125.00K |
| 434 | VERU | Veru Inc. | 35.46M | -0.48% | 198,888 | 16.89M |
| 435 | TELO | Telomir Pharmaceuticals, Inc. | 35.44M | -1.96% | 481,507 | - |
| 436 | EYPT | EyePoint, Inc. | 35.00M | 0.52% | 6,546,986 | 2.58M |
| 437 | ATHE | Alterity Therapeutics Limited | 34.80M | 0.00% | 13,410 | 2.50M |
| 438 | KLRS | Kalaris Therapeutics, Inc. | 34.76M | -7.30% | 157,336 | - |
| 439 | RNTX | Rein Therapeutics Inc. | 34.51M | -27.55% | 8,481,447 | - |
| 440 | NNVC | NanoViricides, Inc. | 31.65M | 0.81% | 89,304 | - |
| 441 | OSTX | OS Therapies Incorporated | 31.45M | -8.63% | 499,340 | - |
| 442 | NXTC | NextCure, Inc. | 30.58M | 4.37% | 37,735 | - |
| 443 | LONA | LeonaBio, Inc. | 30.43M | -6.92% | 58,395 | - |
| 444 | PMN | ProMIS Neurosciences, Inc. | 29.68M | 0.61% | 130,688 | - |
| 445 | ACET | Adicet Bio, Inc. | 29.60M | -1.08% | 595,392 | - |
| 446 | INMB | INmune Bio Inc. | 29.30M | -9.87% | 539,379 | 50.00K |
| 447 | CVM | CEL-SCI Corporation | 29.20M | 29.69% | 1,168,186 | - |
| 448 | BCTX | BriaCell Therapeutics Corp. | 28.87M | -2.65% | 28,959 | - |
| 449 | AARD | Aardvark Therapeutics, Inc. | 27.57M | -5.26% | 215,194 | - |
| 450 | PTHS | Pelthos Therapeutics Inc. | 27.37M | -3.90% | 58,229 | 51.29M |
| 451 | PLRZ | Polyrizon Ltd. | 25.99M | -3.17% | 4,337 | - |
| 452 | MGX | Metagenomi Therapeutics, Inc. | 25.69M | -1.69% | 193,181 | 7.09M |
| 453 | LITS | Lite Strategy, Inc. | 25.60M | 1.16% | 434,604 | - |
| 454 | EVAX | Evaxion A/S | 25.55M | 1.09% | 27,116 | 7.49M |
| 455 | EDSA | Edesa Biotech, Inc. | 25.54M | -2.58% | 473,199 | - |
| 456 | CRVO | CervoMed Inc. | 25.26M | -1.18% | 544,539 | 8.73K |
| 457 | ABVC | ABVC BioPharma, Inc. | 24.41M | 3.30% | 37,859 | 797.92K |
| 458 | BYSI | BeyondSpring Inc. | 23.80M | -3.73% | 61,359 | 1.88M |
| 459 | FLNA | Filana Therapeutics, Inc. | 23.63M | 10.56% | 1,280,879 | - |
| 460 | GRDX | GridAI Technologies Corp. | 23.37M | -11.76% | 430,010 | - |
| 461 | IMMP | Immutep Limited | 23.33M | -2.30% | 26,678 | 13.79M |
| 462 | RNAZ | TransCode Therapeutics, Inc. | 22.86M | 2.27% | 50,416 | - |
| 463 | IGC | IGC Pharma, Inc. | 20.42M | -0.57% | 449,256 | 1.11M |
| 464 | CELU | Celularity Inc. | 20.09M | -1.75% | 106,834 | 18.67M |
| 465 | ATOS | Atossa Therapeutics, Inc. | 19.26M | -1.53% | 69,552 | - |
| 466 | COCP | Cocrystal Pharma, Inc. | 18.83M | -0.24% | 31,247 | 435.00K |
| 467 | LPCN | Lipocine Inc. | 18.38M | -2.92% | 126,728 | 3.74M |
| 468 | BSEM | BioStem Technologies, Inc. | 17.84M | -8.56% | 226,145 | 31.75M |
| 469 | QNRX | Quoin Pharmaceuticals, Ltd. | 17.10M | -3.78% | 19,880 | - |
| 470 | KTTA | Pasithea Therapeutics Corp. | 16.71M | -4.21% | 944,208 | - |
| 471 | ESLA | Estrella Immunopharma, Inc. | 16.53M | -26.07% | 532,633 | - |
| 472 | NCEL | NewcelX Ltd. | 15.88M | 5.36% | 7,106 | - |
| 473 | ABOS | Acumen Pharmaceuticals, Inc. | 15.62M | 0.93% | 2,378,292 | - |
| 474 | CNTX | Context Therapeutics Inc. | 15.24M | -8.24% | 2,875,069 | - |
| 475 | AKTX | Akari Therapeutics, Plc | 14.88M | -4.26% | 28,306 | - |
| 476 | ACTU | Actuate Therapeutics, Inc. | 14.74M | -6.06% | 231,115 | - |
| 477 | TVRD | Tvardi Therapeutics, Inc. | 14.67M | -6.78% | 64,349 | - |
| 478 | CTXR | Citius Pharmaceuticals, Inc. | 14.48M | -1.40% | 150,919 | 7.11M |
| 479 | MCRB | Seres Therapeutics, Inc. | 14.37M | 0.71% | 186,608 | 2.13M |
| 480 | ALLR | Allarity Therapeutics, Inc. | 13.93M | -8.24% | 197,216 | 350.00K |
| 481 | MRKR | Marker Therapeutics, Inc. | 13.82M | -4.76% | 135,857 | 3.55M |
| 482 | NEUP | Neuphoria Therapeutics Inc. | 13.42M | -2.75% | 23,377 | 1.17M |
| 483 | ATYR | aTyr Pharma, Inc. | 13.36M | -14.24% | 39,452 | 190.00K |
| 484 | PASG | Passage Bio, Inc. | 13.29M | -2.82% | 16,997 | - |
| 485 | GUTS | Fractyl Health, Inc. | 13.16M | 9.76% | 648,197 | 3.00K |
| 486 | JSPR | Jasper Therapeutics, Inc. | 13.05M | -13.96% | 23,437 | - |
| 487 | KYNB | Kyntra Bio, Inc. | 12.96M | -6.98% | 59,747 | 4.62M |
| 488 | PLUR | Pluri Inc. | 12.84M | -0.95% | 23,700 | 1.46M |
| 489 | QNTM | Quantum BioPharma Ltd. | 12.62M | -10.56% | 123,189 | - |
| 490 | BCDA | BioCardia, Inc. | 11.96M | -4.92% | 61,192 | 3.00K |
| 491 | RADX | Radiopharm Theranostics Limited | 11.83M | 1.00% | 71,254 | 8.90M |
| 492 | CMMB | Chemomab Therapeutics Ltd. | 11.74M | 5.88% | 72,368 | - |
| 493 | DYAI | Dyadic International, Inc. | 11.66M | -2.14% | 74,706 | 3.09M |
| 494 | BIVI | BioVie Inc. | 11.58M | -4.42% | 160,203 | - |
| 495 | DARE | Daré Bioscience, Inc. | 11.49M | -11.13% | 201,443 | 1.37M |
| 496 | BOLT | Bolt Biotherapeutics, Inc. | 11.40M | -4.61% | 115,705 | 4.70M |
| 497 | PPBT | Purple Biotech Ltd | 10.81M | 3.07% | 28,651 | - |
| 498 | PBM | Psyence Biomedical Ltd. | 10.79M | -10.02% | 43,122 | - |
| 499 | HIND | Vyome Holdings, Inc. | 10.74M | -3.16% | 5,765 | 153.10K |
| 500 | PTN | Palatin Technologies, Inc. | 10.66M | -1.69% | 18,866 | 13.19M |